OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Clinical Microbiology & Infectious Diseases is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)

Article	Citations
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection	458
Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome	192
Transmission of SARS-CoV-2: an update of current literature	99
Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship	94
Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review	90
Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review	87
Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France	81
Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile	81
Vertical transmission of SARS-CoV-2 infection and preterm birth	81
Virulence of Helicobacter pylori outer membrane proteins: an updated review	71
Virulence factors and clonal diversity of Staphylococcus aureus in colonization and wound infection with emphasis on diabetic foot infection	66
Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak	66
Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review	52
The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa	52
Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions	46
Ceftazidime-avibactam, meropenen-vaborbactam, and imipenem-relebactam in combination with aztreonam against multidrug-resistant, metallo-β-lactamase-producing Klebsiella pneumoniae	46
Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit	44
Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting	43
Effectiveness of favipiravir in COVID-19: a live systematic review	43
Antimicrobial resistance in Clostridioides difficile	42
Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis	38
Combined throat/nasal swab sampling for SARS-CoV-2 is equivalent to nasopharyngeal sampling	38
Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19	38
Evaluation of three commercial assays for SARS-CoV-2 molecular detection in upper respiratory tract samples	37
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study	37

Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature	36
Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection	36
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays	35
Expression and co-expression analyses of TMPRSS2, a key element in COVID-19	35
Influenza-associated aspergillosis in critically-ill patients—a retrospective bicentric cohort study	34
Impact of cerebrospinal fluid syndromic testing in the management of children with suspected central nervous system infection	33
Multinational evaluation of the BioFire® FilmArray® Pneumonia plus Panel as compared to standard of care testing	33
Sensitive detection and quantification of SARS-CoV-2 by multiplex droplet digital RT-PCR	33
The role of potentiating mutations in the evolution of pandemic Escherichia coli clones	33